Medical/Pharmaceuticals
China's Largest Commercial GMP Plasmid Manufacturing Facility is Put into Operation, GenScript ProBio Expanding Manufacturing Capacity Again
NANJING, China, Dec. 8, 2021 /PRNewswire/ -- On December 7th, the "Opening Ceremony of GenScript ProBio Plasmid Commercial GMP Manufacturing facility and Open Day" was rounded off. GenScript ProBio at the opening ceremony announced thatthe largest commercial GMP plasmid manufacturing facility in ...
2021-12-08 18:22
3864
AXA Hong Kong launched exclusive mind health network and online counselling service for Employee Benefits customers
HONG KONG, Dec. 8, 2021 /PRNewswire/ -- As a leading Employee Benefits insurance provider, AXA Hong Kong (AXA) continuously enhances its services to working individuals with a commitment to safeguarding all aspects of their physical and mental wellbeing. To enhance mental health support and to ma...
2021-12-08 18:00
3272
SHL Medical Publishes its Molly Modular Autoinjector Platform Technology White Paper
ZUG, Switzerland, Dec. 8, 2021 /PRNewswire/ -- SHL Medical, a world-leading solutions provider in the design, development, and manufacturing of self-injection devices, announced the publication of its white paper titled, "Molly® Autoinjector: A Systematic Review of Molly's Integrated and Flexible...
2021-12-08 14:00
5473
GSK Provides Update on Manufacturing Operations in Singapore
SINGAPORE, Dec. 8, 2021 /PRNewswire/ -- GSK announced today that it will cease manufacturing and outsource all production of amoxicillin that is currently produced at its Quality Road site inSingapore. Amoxicillin is an active pharmaceutical ingredient (API) in GSK's Augmentin product. This will ...
2021-12-08 09:30
4794
Henlius' Phase 3 clinical study of novel PD-1 inhibitor serplulimab for the treatment of first-line extensive-stage small cell lung cancer (ES-SCLC) meets primary study endpoint
SHANGHAI, Dec. 8, 2021 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the first interim analysis met the primary study endpoint of the overall survival (OS) of the Phase 3 clinical study (NCT04063163) of its innovative PD-1 inhibitor serplulimab in combination with chemot...
2021-12-08 08:30
4294
Venus Medtech Acquires Cardiovalve to Optimize its Innovative Products Pipeline of Mitral and Tricuspid Valve Replacement
HANGZHOU, China, Dec. 8, 2021 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (Venus MedTech, 2500.HK), a leading, innovative Chinese structural heart disease treatment company, announced its acquisition of Cardiovalve Ltd. (Cardiovalve), a pioneering transcatheter mitral and tricuspid valve treatm...
2021-12-08 08:28
5072
Ping An's AI-driven AskBob Doctor Earns Top Scores in Diabetes Management Competition
HONG KONG and SHANGHAI, Dec. 8, 2021 /PRNewswire/ -- Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An" or the "Group", HKEx:2318; SSE:601318) announced that its AskBob Doctor, an artificial intelligence-driven consultation and treatment assistance tool, scored an average of 92....
2021-12-08 05:44
5148
CP-COV03, a niclosamide-based oral antiviral drug, under study as possible cure for COVID-19 variants
SUMMARY CP-COV03, a niclosamide-based oral antiviral drug, to cure COVID-19 variants CP-COV03 is a broad-spectrum antiviral drug candidate, developed by Hyundai Bioscience to treat COVID-19. Its active pharmaceutical ingredient is niclosamide, an anthelmintic drug, and is expected to work on var...
2021-12-07 22:00
3366
Global Cord Blood Corporation Announces Results of 2021 Annual General Meeting
HONG KONG, Dec. 7, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced the results of its 2021 Annual Gene...
2021-12-07 21:35
3423
Sino Biological newly launched a panel of research reagents for SARS-CoV-2 Omicron variant
BEIJING, China, Dec. 7, 2021 /PRNewswire/ -- Sino Biological, Inc. (
http://www.sinobiological.com
2021-12-07 18:18
6409
Overland Pharmaceuticals Partners with ArisGlobal to Accelerate Safety Capabilities
Premier pharmaceutical company adopts LifeSphere Multivigilance to centralize pharmacovigilance activities MIAMI, Dec. 7, 2021 /PRNewswire/ -- ArisGlobal, the leading provider of life sciences software that automates core drug development with its end-to-end drug development technology platform ...
2021-12-07 17:13
3190
QUOMI Launches An Innovative, Premium, Digital, Community Network For Healthcare Professionals (HCP)
DORTMUND, Germany, Dec. 7, 2021 /PRNewswire/ -- QUOMI
2021-12-07 09:20
3305
GSK Singapore Announces Additional Supply of Monoclonal Antibody Sotrovimab to the Government of Singapore
* GSK Singapore is contracted to supply the Government of Singapore with additional doses of sotrovimab, following the first purchase placed by the Ministry of Health (MOH) inJune 2021 * Sotrovimab was approved by the Singapore Health Sciences Authority (HSA) under the Pandemic Special Access...
2021-12-07 08:00
3068
Innovent Releases Results of a Phase 1 Clinical Study of IBI362, a Dual Glucagon-like Peptide-1 and Glucagon Receptor Agonist in Chinese Patients with Type 2 Diabetes at the International Diabetes Federation Congress 2021
SAN FRANCISCO and SUZHOU, China, Dec. 7, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other major dis...
2021-12-07 08:00
4525
Gan & Lee Pharmaceuticals Announces U.S. FDA Clearance of Investigational New Drug (IND) Application for a Novel Glucagon-Like Peptide-1 Analogue, GZR18
BEIJING and BRIDGEWATER, N.J., Dec. 7, 2021 /PRNewswire/ -- Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee, stock code: 603087.SH), is pleased to announce that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for the...
2021-12-07 05:54
4405
RaySearch receives large RayStation order in China for carbon ion treatment planning
RaySearch Laboratories AB (publ) announces a large order for the treatment planning system RayStation®* by Lanzhou Ion Therapy Co, LTD, a Chinese manufacturer of accelerator systems for carbon ion therapy STOCKHOLM, Dec. 7, 2021 /PRNewswire/ -- Carbon ion therapy is a highly advanced radiation t...
2021-12-07 05:51
3266
Moscow ranked first among European cities in the ranking of innovations against COVID-19
Moscow ranks third in the world, behind New York and San Francisco MOSCOW, Dec. 7, 2021 /PRNewswire/ -- Moscow is recognized as the first European city in the ranking of innovations, that are used for the formation of resilience to the coronavirus. It is ahead ofLondon and Barcelona. The Russian...
2021-12-07 02:34
5256
Effort to reduce burden of disease in Australia shines spotlight on natural medicine to support liver health
SYDNEY, Dec. 7, 2021 /PRNewswire/ -- The prevalence of liver health issues is emerging as a serious cost and health burden forAustralia with the spotlight on evidence-based natural ingredients that might help support liver health and possibly assist in reducing the burden of the disease[i]. A ne...
2021-12-07 01:00
3023
Broncus enter into strategic partnership with New Frontier Health Corporation /United Family Healthcare
HANGZHOU, China, Dec. 6, 2021 /PRNewswire/ -- Broncus Holding Corporation (2216.HK) ("Broncus"), the leader of minimally invasive diagnostic and therapeutic technology for solutions to different lung diseases inChina, today announced that it has entered into a strategic cooperation framework agre...
2021-12-06 21:44
4889
RedHill Biopharma Reports that Opaganib Mechanism Not Impacted by Viral Spike-Protein Mutations, Including Omicron Mutations
Unique Mode of Action Opaganib works by targeting the human host cell rather than the virus itself and is therefore not expected to be impacted by spike protein mutations, providing a strong rationale for its potential to address the Omicron SARS-CoV-2 variant, as well as other variants of conce...
2021-12-06 20:01
5165
Week's Top Stories
Most Reposted
Visa returns as title sponsor for 2026 MAMA AWARDS; Visa Presale registration begins 13 October
[Picked up by 310 media titles]
2026-10-13 10:00
Agoda and Emerging Travel Group Enter Strategic Partnership
[Picked up by 292 media titles]
2026-10-15 16:00Food & Hospitality Asia 2027 Redefining Excellence: The Premier Platform for Food & Beverage and Hospitality Innovation
[Picked up by 281 media titles]
2026-10-15 10:00Leading Asian DMC Discova to Attend ITB Asia 2026
[Picked up by 279 media titles]
2026-10-15 12:59
New Asia Forum Targets US$30 Billion in Investment into the New Asia at Its Inaugural Edition in Bali
[Picked up by 275 media titles]
2026-10-09 13:21Most Read
Amap and Sands China mark the delivery of the first Tutu robots, with expected indoor navigation and 3D resort previews
2026-10-10 16:43
15612
Sonilo Raises $11M to Build the AI-Native Audio Stack for Video
2026-10-15 00:00
13816